Cargando…

Coexpression of lymphocyte-activation gene 3 and programmed death ligand-1 in tumor infiltrating immune cells predicts worse outcome in renal cell carcinoma

OBJECTIVES: Lymphocyte-activation gene 3 (LAG-3) represents a potential immune checkpoint target for cancer treatment. We investigated LAG-3 expression and its prognostic value in patients with surgically treated clear cell renal cell carcinoma (RCC) and correlated LAG-3 expression with programmed c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chan Ho, Jung, Soo Jin, Seo, Won Ik, Chung, Jae Il, Lee, Dae Sim, Jeong, Dae Hoon, Jeon, Youkyoung, Choi, Inhak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465593/
https://www.ncbi.nlm.nih.gov/pubmed/36083857
http://dx.doi.org/10.1177/03946320221125588